Life Sciences and Healthcare
Arranged an equity investment for a company that develops and manufactures advanced absorbent systems for critical rebreathing and life support applications.
Co-placement agent for $3.5 million Series A Preferred Stock for this innovator and manufacturer of minimally invasive implants and instrument systems for the treatment of various pathologies of the spine.
Strategic advisor for $48 million financing for Cybear Inc. which focuses on internet-based products and services which improve the day-to-day tasks of healthcare providers. *
Private placement for
this designer and manufacturer of thermodynamic systems utilizing proprietary heat transfer technology to process, store and retrieve blood products and biological tissues. *
Series A equity financing arranged for a four-year-old company providing complex co-working space and services to the life sciences industry in multiple US locations.
The company needed investors who understood the life sciences and real estate industries. Avalon identified a family office and private equity firm with relevant industry experience to complete the transaction. Funds will be used to enable expansion to additional locations throughout the US and internationally.
Raised $13.3 million of equity in private placements for generic pharmaceutical company and advised Royce in merger with Watson Pharmaceuticals valued at approximately $100 million. *
Sole placement agent in a registered direct offering to institutional investors for a producer of regenerative biotherapies used for wound care, inflammation and angiogenesis. *
Sole Placement Agent for public company providing pharmacy dispensing, billing and administrative services to doctors office and independent pharmacies.
$4.2 million PIPE for BEI Medical Systems to commercialize Hydro ThermAblator® its proprietary treatment for women's health issues. The company was subsequently sold to Boston Scientific for $95 million.
$Financial advisor for $12.4 million and $3.9 million PIPEs and $20.5 million secondary public offering for this developer of regenerative tissue, use for grafts and other surgeries; subsequently purchased by Kinetic Concepts for $1.7 billion. *
Transaction advisor for clinical-stage biopharmaceutical company focused on treatment of viral infections, inflammatory diseases, and various cancers using a small molecule nucleotide platform.
Capital and transaction advisor to Reproductive Solutions Inc and a strategic acquirer for scaling and commercialization of a disruptive medical device
Exclusive placement agent for biopharmaceutical company developing drugs for rare and orphan diseases. *
Co-placement agent for a $2.25 million private financing for MedLink International, Inc. (OTCBB:MLKNA), a healthcare information business providing electronic health record and practice management applications for physician practices.
Private placement for public pharmaceutical company that develops novel therapeutic products for the treatment of chronic diseases.*
Arranged Series A Equity for Elemeno Health, a cloud-based SaaS solution for frontline healthcare teams. Their microlearning solution is designed to advance quality and patient safety at the point of care.